A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
null nullJens D LundgrenBirgit GrundChristina E BarkauskasThomas L HollandRobert L GottliebUriel SandkovskySamuel M BrownKirk U KnowltonWesley H SelfD Clark FilesMamta K JainThomas BenfieldMichael E BowdishBradley G LeshnowerJason V BakerJens-Ulrik JensenEdward M GardnerAdit A GindeEstelle S HarrisIsik S JohansenNorman MarkowitzMichael A MatthayLars ØstergaardChristina C ChangVictoria J DaveyAnna GoodmanElizabeth S HiggsDaniel D MurrayThomas A MurrayRoger ParedesMahesh K B ParmarAndrew N PhillipsCavan ReillyShweta SharmaRobin L DewarMarc TeitelbaumDeborah WentworthHuyen CaoPaul KlekotkaAbdel G BabikerAnnetine C GelijnsVirginia L KanMark N PolizzottoB Taylor ThompsonHenry Clifford LaneJames D NeatonPublished in: The New England journal of medicine (2020)
Monoclonal antibody LY-CoV555, when coadministered with remdesivir, did not demonstrate efficacy among hospitalized patients who had Covid-19 without end-organ failure. (Funded by Operation Warp Speed and others; TICO ClinicalTrials.gov number, NCT04501978.).